Press release
Oncology/Anti-cancer drugs Market, Growing Analysis, Forecast 2022
For More Info, Get Sample : http://bit.ly/2zb0cnd
The LAMEA oncology drugs market is segmented into therapeutic modalities, cancer types and countries. Therapeutic modalities segment is further categorized into chemotherapy, targeted therapy, immunotherapy (biologic therapy), hormonal therapy and others. The LAMEA oncology drugs market is expected to reach $17,072.2 million by 2021. Patent expiration of key anti-cancer drugs such as Herceptin (Patent Expiration: EU-2014; US-2019), Erbitux (Patent Expiration: EU-2014; US-2016), Rituxan (Patent Expiration: EU-2013; US-2018) and Avastin (Patent Expiration: EU-2018; US-2019), is expected to boost the growth of cancer biosimilars market by 2021. Further, the biological therapy is the fastest growing segment at a CAGR of 12.2%, throughout the analysis period, on account of high efficacy and target specific action. Moreover, blood cancer drugs market was the largest revenue generating application segment in 2015, owing to the high cost of drugs (immunotherapies), used for the treatment of blood cancer.
Based on countries the LAMEA region is segmented into nine countries named Brazil, Argentina, Nigeria, South Africa, Iraq, Iran, Algeria, Saudi Arabia and Egypt. Brazil dominates the LAMEA market closely followed by Argentina, owing to rising incidence of cancer, high expenditure and gross national income (GNI) of Brazil specifically. In addition, LAMEA market is poised to grow at a promising CAGR of 8.6% during the forecast period. This high growth rate is majorly attributed to the increasing awareness towards advanced therapies, namely immunotherapies and increase in per capita healthcare spending.
The key companies profiled in the report include Amgen Inc., AstraZeneca Plc., Roche Diagnostics, GlaxoSmithKline PLC, Merck & Co., Novartis AG, AbbVie Inc. Sanofi, EIMC United Pharmaceuticals (EUP) and Actavis plc.
Enquire About Report : http://bit.ly/2A3v3RZ
KEY BENEFITS:
• The report provides quantitative analysis of the current market and estimations through 2014-2021 that assists in identifying the prevailing market opportunities.
• The report helps in understanding the strategies adopted by various companies for gaining market share in the anti-cancer drugs market.
• The report provides a comprehensive analysis of factors that drive and restrict the growth of the LAMEA anti-cancer drugs market.
• Market conditions of anti-cancer drugs market across LAMEA region are comprehensively analyzed.
• Competitive intelligence highlights the business practices followed by leading market players across various geographies.
• SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.
LAMEA ONCOLOGY/ANTI-CANCER DRUGS MARKET KEY SEGMENTS:
LAMEA oncology/anti-cancer drugs market is segmented into therapeutic modalities, cancer types and countries.
By Therapeutic modalities
• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others
Also Request For Discount : http://bit.ly/2ys8N7W
By Cancer Types
• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Respiratory/Lung Cancer
• Skin Cancer
• Other Cancers
By Countries
• Brazil
• Argentina
• Nigeria
• South Africa
• Iraq
• Iran
• Algeria
• Saudi Arabia
• Egypt
• Other LAMEA countries
Table Of Content
• CHAPTER 1 INTRODUCTION
• CHAPTER 2 EXECUTIVE SUMMARY
• CHAPTER 3 MARKET OVERVIEW
• CHAPTER 4 LAMEA ONCOLOGY/ANTI-CANCER DRUGS MARKET BY THERAPEUTIC MODALITIES,2014-2021
• CHAPTER 5 LAMEA ONCOLOGY/ANTI-CANCER DRUGS MARKET BY CANCER TYPES,2014-2021
• CHAPTER 6 LAMEA ONCOLOGY/ANTI-CANCER DRUGS MARKET BY COUNTRIES,2014-2021
• CHAPTER 7 COMPANY PROFILES
About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.
Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology/Anti-cancer drugs Market, Growing Analysis, Forecast 2022 here
News-ID: 839803 • Views: …
More Releases from Research Beam Market
Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor…
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period…
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are…
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in…
More Releases for LAMEA
LAMEA Beer Market Size Analysis by Application, Type, and Region: Forecast to LA …
USA, New Jersey- According to Market Research Intellect, the global LAMEA Beer market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The expansion of contemporary retail channels, urbanization, and changing consumer preferences are all contributing factors to the LAMEA beer market's steady but slow growth. Beer…
LAMEA Wine Market 2023 Driving Factors Forecast Research 2029
LAMEA wine market is estimated to grow at a CAGR of 3.5% during the forecast period. In 2018, the market in LAMEA was valued at $17.3 billion and is further estimated to reach $21.9 billion in 2025. The factors contributing to the market growth include increasing demand for alcoholic beverages in emerging economies such as Brazil and South Africa due to their growing population base and increasing consumption of alcohol…
LAMEA IVD Market | Business Development Strategies
LAMEA IVD market size was valued at $7,413 million in 2016, and is projected to reach at $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4137
In vitro diagnostics (IVD) are medical devices and reagents used for examination of the body samples such as blood, tissue, and…
LAMEA Carbon Fiber Market Research and Forecast 2020-2026
The LAMEA carbon fiber market is estimated to grow significantly during the forecast period. The market growth is attributed to the significant presence of major end-user industries of carbon fiber in the region. According to SIPRI, Saudi Arabia had a military expenditure of nearly $63.7 billion, $70.4 billion, and $67.6 billion in 2016, 2017, and 2018, respectively. Moreover, the military expenditure of Israel and Iran was $15.9 billion and $13.2…
LAMEA Aerospace Carbon Fiber Market Research and Forecast 2020-2026
LAMEA aerospace carbon fiber market is estimated to grow significantly during the forecast period owing to the growing aerospace industry. As per the Aerospace Industries Association of Brazil in 2017, with around 100 facilities for aircraft manufacturing, the state accounts for 73.0% of Brazil units. The Brazilian aerospace industry is the largest and the most vital in the Southern Hemisphere. Brazil has been among the top 10 export destinations for…
LAMEA Tea Bag Market Trends, Size, Forecast - 2019-2025
LAMEA tea bag market is estimated to grow at a CAGR of 6.0% during the forecast period. Brazil is considered as one of the countries with a significant consumption and production of coffee and tea in Latin America. With the growing health and wellness concerns, the Brazilian consumers' decisions to buy tea are based on their antioxidant and other beneficial properties, which in turn, is likely to increase consumption of…
